92 related articles for article (PubMed ID: 10036146)
1. Development of a scintillation proximity assay for histone deacetylase using a biotinylated peptide derived from histone-H4.
Nare B; Allocco JJ; Kuningas R; Galuska S; Myers RW; Bednarek MA; Schmatz DM
Anal Biochem; 1999 Feb; 267(2):390-6. PubMed ID: 10036146
[TBL] [Abstract][Full Text] [Related]
2. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening.
Ciossek T; Julius H; Wieland H; Maier T; Beckers T
Anal Biochem; 2008 Jan; 372(1):72-81. PubMed ID: 17868634
[TBL] [Abstract][Full Text] [Related]
3. A spectrophotometric assay for histone deacetylase 8.
Fatkins DG; Zheng W
Anal Biochem; 2008 Jan; 372(1):82-8. PubMed ID: 17920554
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.
Park YW; Cummings RT; Wu L; Zheng S; Cameron PM; Woods A; Zaller DM; Marcy AI; Hermes JD
Anal Biochem; 1999 Apr; 269(1):94-104. PubMed ID: 10094779
[TBL] [Abstract][Full Text] [Related]
5. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
He X; Mueller JP; Reynolds KA
Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 3 is selectively involved in L3MBTL2-mediated transcriptional repression.
Yoo JY; Choi KC; Kang H; Kim YJ; Lee J; Jun WJ; Kim MJ; Lee YH; Lee OH; Yoon HG
FEBS Lett; 2010 Jun; 584(11):2225-30. PubMed ID: 20385135
[TBL] [Abstract][Full Text] [Related]
7. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer.
Riester D; Hildmann C; Schwienhorst A; Meyer-Almes FJ
Anal Biochem; 2007 Mar; 362(1):136-41. PubMed ID: 17250798
[TBL] [Abstract][Full Text] [Related]
11. Development of a scintillation proximity assay for human cytomegalovirus protease using 33phosphorous.
Baum EZ; Johnston SH; Bebernitz GA; Gluzman Y
Anal Biochem; 1996 May; 237(1):129-34. PubMed ID: 8660547
[TBL] [Abstract][Full Text] [Related]
12. A scintillation proximity assay for UDP-GalNAc:polypeptide, N-acetylgalactosaminyltransferase.
Baker CA; Poorman RA; Kézdy FJ; Staples DJ; Smith CW; Elhammer AP
Anal Biochem; 1996 Jul; 239(1):20-4. PubMed ID: 8660620
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate).
Turlais F; Hardcastle A; Rowlands M; Newbatt Y; Bannister A; Kouzarides T; Workman P; Aherne GW
Anal Biochem; 2001 Nov; 298(1):62-8. PubMed ID: 11673896
[TBL] [Abstract][Full Text] [Related]
14. First non-radioactive assay for in vitro screening of histone deacetylase inhibitors.
Hoffmann K; Brosch G; Loidl P; Jung M
Pharmazie; 2000 Aug; 55(8):601-6. PubMed ID: 10989838
[TBL] [Abstract][Full Text] [Related]
15. Surrogate alcohols and their metabolites modify histone H3 acetylation: involvement of histone acetyl transferase and histone deacetylase.
Choudhury M; Shukla SD
Alcohol Clin Exp Res; 2008 May; 32(5):829-39. PubMed ID: 18336638
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylation is involved in activation of CXCL10 upon IFNgamma stimulation.
Guo JJ; Li QL; Zhang J; Huang AL
Mol Cells; 2006 Oct; 22(2):163-7. PubMed ID: 17085967
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
18. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.
Epping MT; Bernards R
Int J Biochem Cell Biol; 2009 Jan; 41(1):16-20. PubMed ID: 18765293
[TBL] [Abstract][Full Text] [Related]
20. In vitro assays for the determination of histone deacetylase activity.
Heltweg B; Trapp J; Jung M
Methods; 2005 Aug; 36(4):332-7. PubMed ID: 16087348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
